1. 1 MILO/ENGOT-OV11: Phase-3 study of binimetinib versus physician's choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum. (18th September 2019) Authors: Grisham, R; Monk J, B; Banerjee, S; Coleman L, R; Oza M, A; Oehler K, M; Kalbacher, E; Mirza Raza, M; del Campo M, J; Marth, C; Westermann, A; Pignata, S; Colombo, N; Cibula, D; Hilpert, F; Aghajanian, C; Drill, E; Sandor, V; Boyd P, A; Vergote, I Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 323 ENGOT-en9/LEAP-001: a phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer. (13th November 2020) Authors: Randall, L; Marth, C; Vulsteke, C; Jesús Rubio, M; Makker, V; Braicu, I; McNeish, I; Madry, R; Ayhan, A; Hasegawa, K; Wu, X; Dutta, L; Xu, C; Keefe, S; Lee, J; Pignata, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 439 Primary symptoms in women with different histopathological subtypes of gynaecological sarcoma – results of a prospective intergroup registry for gynaecological sarcoma (REGSA – NOGGO RU1). (13th November 2020) Authors: Roser, E; Pietzner, K; Brucker, S; Harter, P; Zocholl, D; Gimpel, A; Kalder, M; Bossart, M; Strauß, H; Wimberger, P; Armbrust, R; Marth, C; Fehm, T; Jurcikova, P; Mustea, A; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 939PDQuality of life and symptoms in longterm survivors with ovarian cancer: It's still an issue. Expression VI – Carolin meets HANNA – holistic analysis of long-term survival with ovarian cancer: The international NOGGO, ENGOT and GCIG survey. (23rd October 2018) Authors: Woopen, H; Braicu, I; Richter, R; Schnuppe, K; Krabisch, P; Boxler, T; Emons, G; Glajzer, J; Rose, M; Erdur, L; Lindhorst, R; Endres, M; Hühnchen, P; Vergote, I B; Berger, R; Marth, C; Sehouli, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP1004 Prognostic impact of BRCA2 mRNA expression in ovarian cancer: validation using the TCGA cohort. (1st November 2019) Authors: Tsibulak, I; Hackl, H; Wieser, V; Welponer, H; Degasper, C; Leitner, K; Knoll, K; Fiegl, H; Zeimet, AG; Marth, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EP891 Receptor activator of nuclear factor kappa-B ligand expression predicts ovarian cancer outcome. (1st November 2019) Authors: Kögl, J; Wieser, V; Sprung, S; Fiegl, H; Marth, C; Zeimet, AG Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P132 Significance of locus-specific TP53 mutations in ovarian cancer. (1st November 2019) Authors: Knoll, K; Berger, A; Tsibulak, I; Leitner, K; Degasper, C; Welponer, H; Wieser, V; Marth, C; Fiegl, H; Zeimet, A-G Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P139 The role of transcriptomic SMARCA4 expression in ovarian cancer biology. (1st November 2019) Authors: Leitner, K; Wieser, V; Tsibulak, I; Degasper, C; Welponer, H; Knoll, K; Reimer, D; Wiedemair, A; Marth, C; Fiegl, H; Zeimet, AG Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P155 The microRNA 34 family and its clinical significance in ovarian cancer. (1st November 2019) Authors: Welponer, H; Tsibulak, I; Wieser, V; Degasper, C; Shivalingaiah, G; Wenzel, S; Sprung, S; Marth, C; Fiegl, H; Zeimet, AG Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The European Network of Gynecological Oncological Trial Groups. (January 2012) Authors: Vergote, I; Pujade-Lauraine, E; Pignata, S; Kristensen, GB; Ledermann, J; Casado, A; Sehouli, J; Mirza, M; Fossati, R; Marth, C; Ottevanger, N; Del Campo, J; Siddiqui, N; Calvert, P; Bamias, A; Tulunay, G; Van der Zee, AGJ; du Bois, A Journal: Clinical investigation Issue: Volume 2:Number 1(2012) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗